Institutional Ownership
Sensei Biotherapeutics Inc
CUSIP 81728A207COM NEWSNSEQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
9.9%
Max % of class reported
Institutional Holders
28
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Feb 25, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 25, 2026 | Trails Edge Capital Partners, LP | 13G | 9.9% | 126.0K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vivo Capital, LLC | 722.0K | $22.76M |
| 2 | Cormorant Asset Management, LP | 306.2K | $9.65M |
| 3 | Millennium Management LLC | 146.6K | $4.62M |
| 4 | Franklin Resources Inc | 133.5K | $4.21M |
| 5 | Stempoint Capital LP | 132.9K | $4.19M |
| 6 | Caligan Partners LP | 126.0K | $3.97M |
| 7 | Trails Edge Capital Partners, LP | 125.0K | $3.94M |
| 8 | Marshall Wace, LLP | 65.7K | $2.07M |
| 9 | Goldman Sachs Group Inc | 61.6K | $1.94M |
| 10 | Suvretta Capital Management, LLC | 34.5K | $1.09M |